|
G |
Adam33 |
ADAM metallopeptidase domain 33 |
multiple interactions increases expression |
ISO |
ORMDL3 protein affects the reaction [Benomyl results in increased expression of ADAM33 protein] |
CTD |
PMID:27784618 |
|
NCBI chr 3:118,262,395...118,283,456
Ensembl chr 3:118,271,029...118,283,461
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases expression |
EXP |
Benomyl results in decreased expression of AKT1 mRNA |
CTD |
PMID:33930522 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Aldh2 |
aldehyde dehydrogenase 2 family member |
decreases activity |
ISO EXP |
Benomyl metabolite results in decreased activity of ALDH2 protein; Benomyl results in decreased activity of ALDH2 protein |
CTD |
PMID:9585485 PMID:10513990 PMID:11142365 PMID:15331769 PMID:17010440 |
|
NCBI chr12:34,949,549...34,982,527
Ensembl chr12:34,901,219...34,982,521
|
|
G |
Aldh5a1 |
aldehyde dehydrogenase 5 family, member A1 |
decreases activity |
EXP |
Benomyl results in decreased activity of ALDH5A1 protein |
CTD |
PMID:17010440 |
|
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
|
|
G |
Ampd3 |
adenosine monophosphate deaminase 3 |
decreases expression |
EXP |
Benomyl results in decreased expression of AMPD3 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr 1:164,884,823...164,929,899
Ensembl chr 1:164,885,320...164,929,887
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
Benomyl inhibits the reaction [Dihydrotestosterone affects the localization of and results in increased phosphorylation of AR protein] |
CTD |
PMID:25324206 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions |
ISO |
Benomyl inhibits the reaction [BCL2 protein binds to BAX protein] |
CTD |
PMID:16903866 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions increases phosphorylation |
ISO |
Benomyl inhibits the reaction [BCL2 protein binds to BAX protein] Benomyl results in increased phosphorylation of BCL2 protein |
CTD |
PMID:16903866 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
increases expression |
ISO |
Benomyl results in increased expression of BUB1B protein |
CTD |
PMID:16903866 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
Car2 |
carbonic anhydrase 2 |
increases expression |
EXP |
Benomyl results in increased expression of CA2 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr 2:86,741,625...86,756,766
Ensembl chr 2:86,741,626...86,756,818
|
|
G |
Ccl17 |
C-C motif chemokine ligand 17 |
increases expression multiple interactions |
ISO |
Benomyl results in increased expression of CCL17 mRNA ORMDL3 protein affects the reaction [Benomyl results in increased expression of CCL17 mRNA] |
CTD |
PMID:27784618 |
|
NCBI chr19:10,202,128...10,203,903
Ensembl chr19:10,202,128...10,203,819
|
|
G |
Ccnb1 |
cyclin B1 |
increases response to substance |
ISO |
CCNB1 protein results in increased susceptibility to Benomyl |
CTD |
PMID:11960377 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Ccnb2 |
cyclin B2 |
increases response to substance |
ISO |
CCNB2 protein results in increased susceptibility to Benomyl |
CTD |
PMID:11960377 |
|
NCBI chr 8:71,087,594...71,100,794
Ensembl chr 8:71,087,595...71,100,874
|
|
G |
Cd38 |
CD38 molecule |
decreases expression |
EXP |
Benomyl results in decreased expression of CD38 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr14:67,172,062...67,212,328
Ensembl chr14:67,172,063...67,211,986
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
decreases expression multiple interactions |
ISO |
Benomyl results in decreased expression of CYP17A1 mRNA Benomyl results in decreased expression of and results in decreased activity of CYP17A1 protein |
CTD |
PMID:25324206 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases activity increases expression |
ISO |
Benomyl results in increased activity of CYP19A1 protein Benomyl results in increased expression of CYP19A1 mRNA |
CTD |
PMID:14691014 PMID:25543211 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Ddit3 |
DNA-damage inducible transcript 3 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [Benomyl results in increased expression of DDIT3 protein]; MitoTEMPO inhibits the reaction [Benomyl results in increased expression of DDIT3 protein] |
CTD |
PMID:27784618 |
|
NCBI chr 7:63,115,645...63,121,203
Ensembl chr 7:63,116,380...63,121,201
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases expression multiple interactions |
ISO |
Benomyl results in increased expression of EIF2AK3 protein Acetylcysteine inhibits the reaction [Benomyl results in increased expression of EIF2AK3 protein]; MitoTEMPO inhibits the reaction [Benomyl results in increased expression of EIF2AK3 protein] |
CTD |
PMID:27784618 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [Benomyl results in increased expression of ERN1 protein]; MitoTEMPO inhibits the reaction [Benomyl results in increased expression of ERN1 protein] |
CTD |
PMID:27784618 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions affects binding |
ISO |
Benomyl binds to and results in increased activity of ESR1 protein; Benomyl inhibits the reaction [Estradiol binds to ESR1 protein] Benomyl binds to ESR1 protein |
CTD |
PMID:14579009 PMID:16626760 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Fgfr4 |
fibroblast growth factor receptor 4 |
increases expression |
EXP |
Benomyl results in increased expression of FGFR4 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr17:9,461,541...9,476,268
Ensembl chr17:9,461,547...9,476,242
|
|
G |
Gipc1 |
GIPC PDZ domain containing family, member 1 |
increases expression |
EXP |
Benomyl results in increased expression of GIPC1 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr19:24,474,291...24,487,083
Ensembl chr19:24,453,123...24,486,997
|
|
G |
Glyat |
glycine-N-acyltransferase |
increases expression |
EXP |
Benomyl results in increased expression of GLYAT mRNA |
CTD |
PMID:15885261 |
|
NCBI chr 1:209,704,213...209,724,949
Ensembl chr 1:209,704,268...209,724,942
|
|
G |
Hdac1 |
histone deacetylase 1 |
decreases activity |
ISO |
Benomyl results in decreased activity of HDAC1 protein |
CTD |
PMID:25543211 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression multiple interactions |
ISO |
Benomyl results in increased expression of HSPA5 protein Acetylcysteine inhibits the reaction [Benomyl results in increased expression of HSPA5 protein]; MitoTEMPO inhibits the reaction [Benomyl results in increased expression of HSPA5 protein] |
CTD |
PMID:27784618 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspb1 |
heat shock protein family B (small) member 1 |
increases expression |
EXP |
Benomyl results in increased expression of HSPB1 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr12:20,794,014...20,795,675
Ensembl chr12:20,794,028...20,795,743
|
|
G |
Ifnb1 |
interferon beta 1 |
multiple interactions |
ISO |
Benomyl inhibits the reaction [Lipopolysaccharides results in increased expression of IFNB1 mRNA] |
CTD |
PMID:18177342 |
|
NCBI chr 5:103,020,758...103,021,595
Ensembl chr 5:103,020,969...103,021,523
|
|
G |
Itga5 |
integrin subunit alpha 5 |
decreases expression |
ISO |
Benomyl results in decreased expression of ITGA5 mRNA |
CTD |
PMID:25530041 |
|
NCBI chr 7:134,478,963...134,502,837
Ensembl chr 7:134,478,968...134,502,837
|
|
G |
Itgb1 |
integrin subunit beta 1 |
decreases expression |
ISO |
Benomyl results in decreased expression of ITGB1 mRNA |
CTD |
PMID:25530041 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Klk1c10 |
kallikrein 1-related peptidase C10 |
multiple interactions |
ISO |
Benomyl inhibits the reaction [Dihydrotestosterone results in increased secretion of KLK3 protein] |
CTD |
PMID:25324206 |
|
NCBI chr 1:94,402,993...94,407,052
Ensembl chr 1:94,402,993...94,407,052
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases expression |
EXP |
Benomyl results in increased expression of MAPK8 mRNA |
CTD |
PMID:33930522 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mir21 |
microRNA 21 |
decreases expression |
EXP |
Benomyl results in decreased expression of MIR21 mRNA |
CTD |
PMID:33930522 |
|
NCBI chr10:71,405,257...71,405,348
Ensembl chr10:71,405,257...71,405,348
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression multiple interactions increases expression |
ISO |
Benomyl results in decreased expression of MMP2 mRNA ORMDL3 protein affects the reaction [Benomyl results in increased expression of MMP2 protein] |
CTD |
PMID:25530041 PMID:27784618 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression |
EXP ISO |
Benomyl results in decreased expression of MMP9 protein Benomyl results in decreased expression of MMP9 mRNA |
CTD |
PMID:10026946 PMID:25530041 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mmrn1 |
multimerin 1 |
increases expression |
EXP |
Benomyl results in increased expression of MMRN1 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr 4:89,875,408...89,950,814
Ensembl chr 4:89,903,174...89,950,474
|
|
G |
Msmb |
microseminoprotein, beta |
increases expression |
EXP |
Benomyl results in increased expression of MSMB mRNA |
CTD |
PMID:15885261 |
|
NCBI chr16:7,366,536...7,387,124
Ensembl chr16:7,366,536...7,387,123
|
|
G |
Mt2A |
metallothionein 2A |
increases expression |
EXP |
Benomyl results in increased expression of MT2A mRNA |
CTD |
PMID:15885261 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
ISO |
Benomyl inhibits the reaction [Lipopolysaccharides results in increased activity of NFKB1 protein] |
CTD |
PMID:17015962 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
Benomyl inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Or10al27 |
olfactory receptor family 10 subfamily AL member 27 |
increases expression |
EXP |
Benomyl results in increased expression of OR10AL27 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr20:789,272...790,237
Ensembl chr20:761,025...765,744 Ensembl chr20:761,025...765,744
|
|
G |
Or13p4 |
olfactory receptor family 13 subfamily P member 4 |
increases expression |
EXP |
Benomyl results in increased expression of OR13P4 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr 5:132,216,822...132,217,769
Ensembl chr 5:132,215,327...132,221,481
|
|
G |
Or9s23b |
olfactory receptor family 9 subfamily S member 23B |
increases expression |
EXP |
Benomyl results in increased expression of OR9S23B mRNA |
CTD |
PMID:15885261 |
|
NCBI chr 9:93,117,328...93,118,299
Ensembl chr 9:93,115,232...93,123,441
|
|
G |
Ormdl3 |
ORMDL sphingolipid biosynthesis regulator 3 |
multiple interactions increases expression |
ISO |
Acetylcysteine inhibits the reaction [Benomyl results in increased expression of ORMDL3 protein]; MitoTEMPO inhibits the reaction [Benomyl results in increased expression of ORMDL3 protein]; ORMDL3 protein affects the reaction [Benomyl results in increased expression of ADAM33 protein]; ORMDL3 protein affects the reaction [Benomyl results in increased expression of CCL17 mRNA]; ORMDL3 protein affects the reaction [Benomyl results in increased expression of CXCL8 mRNA]; ORMDL3 protein affects the reaction [Benomyl results in increased expression of MMP2 protein]; ORMDL3 protein affects the reaction [Benomyl results in increased expression of TSLP mRNA] |
CTD |
PMID:27784618 |
|
NCBI chr10:83,590,052...83,596,035
Ensembl chr10:83,590,071...83,598,620
|
|
G |
Park7 |
Parkinsonism associated deglycase |
decreases activity |
ISO |
Benomyl results in decreased activity of PARK7 protein |
CTD |
PMID:36842454 |
|
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
Benomyl results in increased cleavage of PARP1 protein |
CTD |
PMID:16903866 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Plau |
plasminogen activator, urokinase |
decreases expression |
ISO |
Benomyl results in decreased expression of PLAU mRNA |
CTD |
PMID:25530041 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Pten |
phosphatase and tensin homolog |
increases expression |
EXP |
Benomyl results in increased expression of PTEN mRNA |
CTD |
PMID:33930522 |
|
NCBI chr 1:230,630,443...230,697,070
Ensembl chr 1:230,630,338...230,696,838
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases expression |
EXP |
Benomyl results in increased expression of RELA mRNA |
CTD |
PMID:33930522 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Scd |
stearoyl-CoA desaturase |
decreases expression |
EXP |
Benomyl results in decreased expression of SCD1 mRNA |
CTD |
PMID:15885261 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Serpine2 |
serpin family E member 2 |
increases expression |
ISO |
Benomyl results in increased expression of SERPINE2 mRNA |
CTD |
PMID:25530041 |
|
NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826
|
|
G |
Sh2d4a |
SH2 domain containing 4A |
increases expression |
EXP |
Benomyl results in increased expression of SH2D4A mRNA |
CTD |
PMID:15885261 |
|
NCBI chr16:21,339,010...21,409,360
Ensembl chr16:21,340,015...21,409,260
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
ISO |
Benomyl results in increased expression of TIMP1 mRNA |
CTD |
PMID:25530041 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
increases expression |
ISO |
Benomyl results in increased expression of TIMP2 mRNA |
CTD |
PMID:25530041 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tnf |
tumor necrosis factor |
decreases expression |
EXP |
Benomyl results in decreased expression of TNF mRNA |
CTD |
PMID:33930522 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
affects activity |
ISO |
Benomyl affects the activity of TP53 protein |
CTD |
PMID:35435491 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tslp |
thymic stromal lymphopoietin |
increases expression multiple interactions |
ISO |
Benomyl results in increased expression of TSLP mRNA ORMDL3 protein affects the reaction [Benomyl results in increased expression of TSLP mRNA] |
CTD |
PMID:27784618 |
|
NCBI chr18:24,447,409...24,454,244
Ensembl chr18:24,449,844...24,453,548
|
|
G |
Uba1 |
ubiquitin-like modifier activating enzyme 1 |
multiple interactions |
ISO |
Benomyl results in increased activity of and results in increased ubiquitination of UBA1 protein |
CTD |
PMID:25714994 |
|
NCBI chr X:1,508,700...1,530,677
Ensembl chr X:1,508,666...1,530,636
|
|
G |
Vasp |
vasodilator-stimulated phosphoprotein |
multiple interactions |
EXP |
Benomyl inhibits the reaction [Nitroglycerin results in increased phosphorylation of VASP protein]; Benomyl inhibits the reaction [Pentaerythritol Tetranitrate results in increased phosphorylation of VASP protein] |
CTD |
PMID:15331769 |
|
NCBI chr 1:78,910,009...78,925,791
Ensembl chr 1:78,910,011...78,925,061
|
|
|
G |
Abi2 |
abl-interactor 2 |
increases expression |
EXP |
carbendazim results in increased expression of ABI2 mRNA |
CTD |
PMID:22952946 |
|
NCBI chr 9:61,827,186...61,905,703
Ensembl chr 9:61,827,139...61,905,699
|
|
G |
Acaca |
acetyl-CoA carboxylase alpha |
increases expression |
ISO |
carbendazim results in increased expression of ACACA mRNA |
CTD |
PMID:26071454 |
|
NCBI chr10:69,014,261...69,276,453
Ensembl chr10:69,014,170...69,276,457
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions |
EXP |
[carbendazim co-treated with mancozeb] results in increased activity of ACHE protein |
CTD |
PMID:33217513 |
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Agpat2 |
1-acylglycerol-3-phosphate O-acyltransferase 2 |
increases expression |
ISO |
carbendazim results in increased expression of AGPAT2 mRNA |
CTD |
PMID:26071454 |
|
NCBI chr 3:9,416,837...9,428,567
Ensembl chr 3:9,416,843...9,428,371
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions affects localization |
ISO |
AHR protein affects the reaction [carbendazim results in increased expression of CYP1A1 protein] carbendazim affects the localization of AHR protein |
CTD |
PMID:27286660 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Alb |
albumin |
decreases expression |
EXP |
carbendazim results in decreased expression of ALB protein |
CTD |
PMID:35437878 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Anxa10 |
annexin A10 |
increases expression |
ISO |
carbendazim results in increased expression of ANXA10 mRNA |
CTD |
PMID:32194361 |
|
NCBI chr16:27,738,712...27,805,648
Ensembl chr16:27,738,712...27,805,648
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
ISO |
carbendazim results in decreased expression of ARG1 mRNA |
CTD |
PMID:32194361 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Bag1 |
BAG cochaperone 1 |
increases expression |
EXP |
carbendazim results in increased expression of BAG1 mRNA |
CTD |
PMID:22952946 |
|
NCBI chr 5:56,068,494...56,081,075
Ensembl chr 5:56,068,494...56,081,075
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
EXP |
carbendazim results in increased expression of BAX mRNA; carbendazim results in increased expression of BAX protein |
CTD |
PMID:35437878 PMID:35513110 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
EXP |
carbendazim results in decreased expression of BCL2 mRNA |
CTD |
PMID:35437878 PMID:35513110 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl2l14 |
Bcl2-like 14 |
increases expression |
EXP |
carbendazim results in increased expression of BCL2L14 mRNA |
CTD |
PMID:22952946 |
|
NCBI chr 4:167,217,561...167,258,723
Ensembl chr 4:167,219,871...167,258,086
|
|
G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
increases activity |
ISO |
carbendazim results in increased activity of BUB1B protein |
CTD |
PMID:37506866 |
|
NCBI chr 3:105,563,089...105,615,547
Ensembl chr 3:105,563,138...105,615,547
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions increases expression |
ISO EXP |
carbendazim results in increased activity of CASP3 protein Chitosan inhibits the reaction [carbendazim results in increased expression of CASP3 protein] |
CTD |
PMID:30851412 PMID:35705592 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
decreases activity decreases expression multiple interactions |
EXP |
carbendazim results in decreased activity of CAT protein carbendazim results in decreased expression of CAT protein [Chlorpyrifos co-treated with carbendazim] results in decreased activity of CAT protein; Chitosan inhibits the reaction [carbendazim results in decreased expression of CAT protein] |
CTD |
PMID:27268782 PMID:35513110 PMID:35705592 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccnb1 |
cyclin B1 |
increases expression |
ISO |
carbendazim results in increased expression of CCNB1 protein |
CTD |
PMID:37506866 |
|
NCBI chr 2:31,912,190...31,921,163
Ensembl chr 2:31,912,193...31,921,172
|
|
G |
Clca2 |
chloride channel accessory 2 |
multiple interactions |
EXP |
[carbendazim co-treated with 2,5-hexanedione] results in decreased expression of CLCA2 mRNA |
CTD |
PMID:22382377 |
|
NCBI chr 2:233,993,619...234,022,691
Ensembl chr 2:233,995,078...234,022,199
|
|
G |
Cldn11 |
claudin 11 |
multiple interactions |
EXP |
[carbendazim co-treated with iprodione] results in decreased expression of CLDN11 protein |
CTD |
PMID:28576679 |
|
NCBI chr 2:112,207,745...112,221,050
Ensembl chr 2:112,207,745...112,221,050
|
|
G |
Clu |
clusterin |
decreases expression increases expression |
EXP |
carbendazim results in decreased expression of CLU mRNA carbendazim results in increased expression of CLU mRNA |
CTD |
PMID:22952946 PMID:27466211 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
increases activity increases expression |
ISO |
carbendazim results in increased activity of CYP19A1 protein carbendazim results in increased expression of CYP19A1 mRNA |
CTD |
PMID:14691014 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases expression multiple interactions |
ISO EXP |
carbendazim results in increased expression of CYP1A1 mRNA; carbendazim results in increased expression of CYP1A1 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [carbendazim results in increased expression of CYP1A1 protein]; AHR protein affects the reaction [carbendazim results in increased expression of CYP1A1 protein]; salicylamide inhibits the reaction [carbendazim results in increased expression of CYP1A1 protein] |
CTD |
PMID:10103034 PMID:21784029 PMID:27286660 PMID:32194361 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
ISO |
carbendazim results in increased expression of CYP1A2 mRNA; carbendazim results in increased expression of CYP1A2 protein |
CTD |
PMID:21784029 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression |
ISO |
carbendazim results in increased expression of CYP2B6 mRNA |
CTD |
PMID:22310298 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
decreases expression |
ISO |
carbendazim results in decreased expression of CYP2C19 protein |
CTD |
PMID:32194361 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp2d4 |
cytochrome P450, family 2, subfamily d, polypeptide 4 |
decreases activity |
ISO |
carbendazim results in decreased activity of CYP2D6 protein |
CTD |
PMID:20183062 |
|
NCBI chr 7:113,882,584...113,891,754
Ensembl chr 7:113,881,618...113,891,759
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression |
ISO |
carbendazim results in increased expression of CYP3A4 mRNA |
CTD |
PMID:22310298 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
decreases expression |
ISO |
carbendazim results in decreased expression of CYP7A1 mRNA; carbendazim results in decreased expression of CYP7A1 protein |
CTD |
PMID:32194361 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Dgat1 |
diacylglycerol O-acyltransferase 1 |
increases expression |
ISO |
carbendazim results in increased expression of DGAT1 mRNA |
CTD |
PMID:26071454 |
|
NCBI chr 7:108,223,860...108,235,413
Ensembl chr 7:108,218,524...108,234,299
|
|
G |
Dgat2 |
diacylglycerol O-acyltransferase 2 |
increases expression |
ISO |
carbendazim results in increased expression of DGAT2 mRNA |
CTD |
PMID:26071454 |
|
NCBI chr 1:153,454,078...153,484,432
Ensembl chr 1:153,454,080...153,484,428
|
|
G |
Dnaaf11 |
dynein axonemal assembly factor 11 |
decreases expression |
EXP |
carbendazim results in decreased expression of DNAAF11 mRNA |
CTD |
PMID:27466211 |
|
NCBI chr 7:98,141,525...98,245,906
Ensembl chr 7:98,144,763...98,245,837
|
|
G |
Dpp7 |
dipeptidylpeptidase 7 |
multiple interactions |
EXP |
[carbendazim co-treated with 2,5-hexanedione] results in decreased expression of DPP7 mRNA |
CTD |
PMID:22382377 |
|
NCBI chr 3:8,165,091...8,169,343
Ensembl chr 3:8,165,091...8,169,355
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases expression affects localization |
EXP ISO |
carbendazim results in decreased expression of ESR1 mRNA carbendazim affects the localization of ESR1 protein |
CTD |
PMID:28576679 PMID:37506866 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
decreases expression |
EXP |
carbendazim results in decreased expression of ESR2 mRNA |
CTD |
PMID:28576679 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fabp9 |
fatty acid binding protein 9 |
multiple interactions decreases expression |
EXP |
Carnitine inhibits the reaction [carbendazim results in decreased expression of FABP9 mRNA]; Carnitine inhibits the reaction [carbendazim results in decreased expression of FABP9 protein] carbendazim results in decreased expression of FABP9 mRNA; carbendazim results in decreased expression of FABP9 protein |
CTD |
PMID:33965443 |
|
NCBI chr 2:91,591,842...91,595,873
Ensembl chr 2:91,592,298...91,595,873
|
|
G |
Fank1 |
fibronectin type III and ankyrin repeat domains 1 |
increases expression |
EXP |
carbendazim results in increased expression of FANK1 mRNA |
CTD |
PMID:22952946 |
|
NCBI chr 1:188,577,512...188,685,501
Ensembl chr 1:188,577,575...188,685,504
|
|
G |
Foxa2 |
forkhead box A2 |
increases expression |
ISO |
carbendazim results in increased expression of FOXA2 mRNA |
CTD |
PMID:26071454 |
|
NCBI chr 3:135,470,123...135,474,326
Ensembl chr 3:135,470,131...135,474,326
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
decreases expression multiple interactions |
EXP |
carbendazim results in decreased expression of FSHB protein Carnitine inhibits the reaction [carbendazim results in decreased expression of FSHB protein] |
CTD |
PMID:33965443 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
ISO |
carbendazim results in decreased expression of G6PC1 mRNA |
CTD |
PMID:32194361 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gfap |
glial fibrillary acidic protein |
increases expression |
EXP |
carbendazim results in increased expression of GFAP protein |
CTD |
PMID:35513110 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gja1 |
gap junction protein, alpha 1 |
multiple interactions |
EXP |
[carbendazim co-treated with iprodione] results in decreased expression of GJA1 protein |
CTD |
PMID:28576679 |
|
NCBI chr20:35,756,007...35,768,481
Ensembl chr20:35,755,991...35,768,582
|
|
G |
Got1 |
glutamic-oxaloacetic transaminase 1 |
increases secretion multiple interactions |
EXP |
carbendazim results in increased secretion of GOT1 protein Chitosan inhibits the reaction [carbendazim results in increased secretion of GOT1 protein] |
CTD |
PMID:35705592 |
|
NCBI chr 1:242,357,293...242,381,535
Ensembl chr 1:242,357,306...242,380,633
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression increases secretion multiple interactions |
EXP |
carbendazim results in increased expression of GPT protein carbendazim results in increased secretion of GPT protein Chitosan inhibits the reaction [carbendazim results in increased secretion of GPT protein] |
CTD |
PMID:35437878 PMID:35705592 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions decreases expression |
EXP |
Chitosan inhibits the reaction [carbendazim results in decreased expression of HMOX1 mRNA] |
CTD |
PMID:35705592 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Ift81 |
intraflagellar transport 81 |
decreases expression |
EXP |
carbendazim results in decreased expression of IFT81 mRNA |
CTD |
PMID:22952946 PMID:27466211 |
|
NCBI chr12:33,957,744...34,037,164
Ensembl chr12:33,957,806...34,037,057
|
|
G |
Il10 |
interleukin 10 |
multiple interactions decreases expression |
EXP |
Carnitine inhibits the reaction [carbendazim results in decreased expression of IL10 protein] |
CTD |
PMID:33965443 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il1b |
interleukin 1 beta |
increases expression |
ISO EXP |
carbendazim results in increased expression of IL1B mRNA; carbendazim results in increased expression of IL1B protein |
CTD |
PMID:26071454 PMID:35513110 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
increases expression multiple interactions |
ISO EXP |
carbendazim results in increased expression of IL6 mRNA; carbendazim results in increased expression of IL6 protein Carnitine inhibits the reaction [carbendazim results in increased expression of IL6 protein] |
CTD |
PMID:26071454 PMID:33965443 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Itga5 |
integrin subunit alpha 5 |
decreases expression |
ISO |
carbendazim results in decreased expression of ITGA5 mRNA |
CTD |
PMID:25530041 |
|
NCBI chr 7:134,478,963...134,502,837
Ensembl chr 7:134,478,968...134,502,837
|
|
G |
Itgb1 |
integrin subunit beta 1 |
decreases expression |
ISO |
carbendazim results in decreased expression of ITGB1 mRNA |
CTD |
PMID:25530041 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Keap1 |
Kelch-like ECH-associated protein 1 |
multiple interactions increases expression |
EXP |
Chitosan inhibits the reaction [carbendazim results in increased expression of KEAP1 mRNA] |
CTD |
PMID:35705592 |
|
NCBI chr 8:19,768,375...19,777,862
Ensembl chr 8:19,768,375...19,777,862
|
|
G |
Lhb |
luteinizing hormone subunit beta |
decreases expression multiple interactions |
EXP |
carbendazim results in decreased expression of LHB protein Carnitine inhibits the reaction [carbendazim results in decreased expression of LHB protein] |
CTD |
PMID:33965443 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Loxl1 |
lysyl oxidase-like 1 |
multiple interactions increases expression |
EXP |
2,5-hexanedione promotes the reaction [carbendazim results in increased expression of LOXL1 protein]; [carbendazim co-treated with 2,5-hexanedione] results in decreased expression of LOXL1 mRNA |
CTD |
PMID:22382377 |
|
NCBI chr 8:58,691,763...58,716,365
Ensembl chr 8:58,692,593...58,716,356
|
|
G |
Lpl |
lipoprotein lipase |
decreases expression |
ISO |
carbendazim results in decreased expression of LPL protein |
CTD |
PMID:30496565 |
|
NCBI chr16:20,830,055...20,853,855
Ensembl chr16:20,829,465...20,855,249
|
|
G |
Macrod1 |
mono-ADP ribosylhydrolase 1 |
multiple interactions |
EXP |
[carbendazim co-treated with 2,5-hexanedione] results in decreased expression of MACROD1 mRNA |
CTD |
PMID:22382377 |
|
NCBI chr 1:204,246,238...204,387,027
Ensembl chr 1:204,246,166...204,389,716
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
affects localization |
ISO |
carbendazim affects the localization of MAPK1 protein modified form |
CTD |
PMID:37506866 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
affects localization |
ISO |
carbendazim affects the localization of MAPK3 protein modified form |
CTD |
PMID:37506866 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
increases expression |
EXP |
carbendazim results in increased expression of MAPK8 mRNA |
CTD |
PMID:35513110 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mfap3l |
microfibril associated protein 3 like |
increases expression |
EXP |
carbendazim results in increased expression of MFAP3L mRNA |
CTD |
PMID:22952946 |
|
NCBI chr16:29,411,643...29,454,665
Ensembl chr16:29,415,849...29,430,863
|
|
G |
Mir128-1 |
microRNA 128-1 |
increases expression |
EXP |
carbendazim results in increased expression of MIR128-1 mRNA |
CTD |
PMID:32418910 |
|
NCBI chr13:39,699,449...39,699,530
Ensembl chr13:39,699,449...39,699,530
|
|
G |
Mir423 |
microRNA 423 |
increases expression |
EXP |
carbendazim results in increased expression of MIR423 mRNA |
CTD |
PMID:32418910 |
|
NCBI chr10:61,914,142...61,914,220
Ensembl chr10:61,914,133...61,914,226
|
|
G |
Mmp2 |
matrix metallopeptidase 2 |
decreases expression |
ISO |
carbendazim results in decreased expression of MMP2 mRNA |
CTD |
PMID:25530041 |
|
NCBI chr19:14,154,657...14,182,870
Ensembl chr19:14,154,657...14,182,870
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
decreases expression |
ISO |
carbendazim results in decreased expression of MMP9 mRNA |
CTD |
PMID:25530041 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions increases activity |
EXP |
[Chlorpyrifos co-treated with carbendazim] results in increased activity of MPO protein carbendazim results in increased activity of MPO protein |
CTD |
PMID:27268782 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases expression multiple interactions decreases expression |
ISO EXP |
carbendazim results in increased expression of NFE2L2 protein Chitosan inhibits the reaction [carbendazim results in decreased expression of NFE2L2 mRNA] |
CTD |
PMID:30851412 PMID:35705592 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nos2 |
nitric oxide synthase 2 |
multiple interactions increases expression |
EXP |
Carnitine inhibits the reaction [carbendazim results in increased expression of NOS2 protein]; Chitosan inhibits the reaction [carbendazim results in increased expression of NOS2 protein] |
CTD |
PMID:33965443 PMID:35705592 |
|
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
carbendazim inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Ocln |
occludin |
decreases expression multiple interactions |
EXP |
carbendazim results in decreased expression of OCLN protein Carnitine inhibits the reaction [carbendazim results in decreased expression of OCLN protein] |
CTD |
PMID:33965443 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Pim1 |
Pim-1 proto-oncogene, serine/threonine kinase |
increases expression |
EXP |
carbendazim results in increased expression of PIM1 mRNA |
CTD |
PMID:22952946 |
|
NCBI chr20:7,554,921...7,559,174
Ensembl chr20:7,554,921...7,559,174
|
|
G |
Plau |
plasminogen activator, urokinase |
decreases expression |
ISO |
carbendazim results in decreased expression of PLAU mRNA |
CTD |
PMID:25530041 |
|
NCBI chr15:3,456,230...3,462,732
Ensembl chr15:3,456,232...3,462,775
|
|
G |
Ptgds |
prostaglandin D2 synthase |
decreases expression |
EXP |
carbendazim results in decreased expression of PTGDS mRNA |
CTD |
PMID:22952946 |
|
NCBI chr 3:8,281,899...8,284,833
Ensembl chr 3:8,281,899...8,284,833
|
|
G |
Pttg1 |
PTTG1 regulator of sister chromatid separation, securin |
increases expression |
ISO |
carbendazim results in increased expression of PTTG1 protein |
CTD |
PMID:37506866 |
|
NCBI chr10:27,893,466...27,904,965
Ensembl chr10:27,893,689...27,904,837
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases expression multiple interactions |
EXP |
carbendazim results in increased expression of RELA protein Carnitine inhibits the reaction [carbendazim results in increased expression of RELA protein] |
CTD |
PMID:33965443 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Serpine2 |
serpin family E member 2 |
increases expression |
ISO |
carbendazim results in increased expression of SERPINE2 mRNA |
CTD |
PMID:25530041 |
|
NCBI chr 9:81,124,746...81,188,866
Ensembl chr 9:81,124,804...81,188,826
|
|
G |
Shank3 |
SH3 and multiple ankyrin repeat domains 3 |
multiple interactions |
EXP |
[carbendazim co-treated with 2,5-hexanedione] affects the expression of SHANK3 mRNA |
CTD |
PMID:22382377 |
|
NCBI chr 7:120,568,707...120,630,796
Ensembl chr 7:120,570,402...120,630,374
|
|
G |
Sil1 |
SIL1 nucleotide exchange factor |
decreases expression |
EXP |
carbendazim results in decreased expression of SIL1 mRNA |
CTD |
PMID:22952946 PMID:27466211 |
|
NCBI chr18:26,872,423...27,104,365
Ensembl chr18:26,872,429...27,104,332
|
|
G |
Sod3 |
superoxide dismutase 3 |
increases expression |
EXP |
carbendazim results in increased expression of SOD3 mRNA |
CTD |
PMID:27466211 |
|
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
increases expression |
ISO |
carbendazim results in increased expression of SREBF1 mRNA |
CTD |
PMID:26071454 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression multiple interactions |
EXP |
carbendazim results in decreased expression of STAR mRNA; carbendazim results in decreased expression of STAR protein Carnitine inhibits the reaction [carbendazim results in decreased expression of STAR mRNA]; Carnitine inhibits the reaction [carbendazim results in decreased expression of STAR protein] |
CTD |
PMID:33965443 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Tbc1d5 |
TBC1 domain family, member 5 |
decreases expression |
EXP |
carbendazim results in decreased expression of TBC1D5 mRNA |
CTD |
PMID:27466211 |
|
NCBI chr 9:3,503,328...4,017,131
Ensembl chr 9:3,513,623...4,016,913
|
|
G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
increases expression |
ISO |
carbendazim results in increased expression of TIMP1 mRNA |
CTD |
PMID:25530041 |
|
NCBI chr X:1,212,969...1,217,714
Ensembl chr X:1,212,972...1,217,664
|
|
G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
increases expression |
ISO |
carbendazim results in increased expression of TIMP2 mRNA |
CTD |
PMID:25530041 |
|
NCBI chr10:103,541,199...103,590,611
Ensembl chr10:103,531,505...103,590,611
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
EXP |
Carnitine inhibits the reaction [carbendazim results in increased expression of TNF protein] |
CTD |
PMID:33965443 PMID:35437878 PMID:35513110 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnp1 |
transition protein 1 |
increases expression |
EXP |
carbendazim results in increased expression of TNP1 mRNA |
CTD |
PMID:28576679 |
|
NCBI chr 9:74,594,463...74,595,072
Ensembl chr 9:74,594,466...74,595,274
|
|
G |
Tnp2 |
transition protein 2 |
increases expression |
EXP |
carbendazim results in increased expression of TNP2 mRNA |
CTD |
PMID:28576679 |
|
NCBI chr10:4,879,812...4,880,540
Ensembl chr10:4,879,812...4,880,538
|
|
G |
Tp53 |
tumor protein p53 |
increases expression affects activity |
EXP ISO |
carbendazim results in increased expression of TP53 mRNA carbendazim affects the activity of TP53 protein |
CTD |
PMID:35435491 PMID:35513110 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tshb |
thyroid stimulating hormone subunit beta |
increases expression |
EXP |
carbendazim results in increased expression of TSHB protein |
CTD |
PMID:33965443 |
|
NCBI chr 2:190,224,676...190,229,559
Ensembl chr 2:190,224,676...190,229,559
|
|
|
G |
1700012B07Rkl |
RIKEN cDNA 1700012B07 gene like |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of 1700012B07RKL gene |
CTD |
PMID:33854195 |
|
NCBI chr10:94,771,471...94,804,839
Ensembl chr10:94,771,554...94,804,839
|
|
G |
Acot2 |
acyl-CoA thioesterase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ACOT2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 6:103,611,738...103,619,404
Ensembl chr 6:103,611,544...103,619,245
|
|
G |
Acot4 |
acyl-CoA thioesterase 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACOT4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:103,668,699...103,674,037
Ensembl chr 6:103,668,753...103,673,917
|
|
G |
Acy1 |
aminoacylase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ACY1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:107,072,354...107,077,756
Ensembl chr 8:107,072,358...107,077,682
|
|
G |
Adam15 |
ADAM metallopeptidase domain 15 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAM15 gene |
CTD |
PMID:33854195 |
|
NCBI chr 2:174,754,629...174,765,136
Ensembl chr 2:174,754,633...174,765,113
|
|
G |
Adamtsl3 |
ADAMTS-like 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of ADAMTSL3 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:136,288,793...136,596,986
Ensembl chr 1:136,288,793...136,596,986
|
|
G |
Adcy6 |
adenylate cyclase 6 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ADCY6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:129,742,827...129,763,922
Ensembl chr 7:129,742,838...129,763,754
|
|
G |
Adrm1 |
ADRM1 26S proteasome ubiquitin receptor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ADRM1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:167,265,435...167,270,197
Ensembl chr 3:167,265,296...167,270,195
|
|
G |
Afp |
alpha-fetoprotein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of AFP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:17,573,412...17,591,476
Ensembl chr14:17,573,412...17,591,480
|
|
G |
Agt |
angiotensinogen |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of AGT mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:52,529,139...52,549,618
Ensembl chr19:52,529,185...52,540,977
|
|
G |
Aig1 |
androgen-induced 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of AIG1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:8,046,430...8,269,276
Ensembl chr 1:8,046,430...8,269,084
|
|
G |
Akap8 |
A-kinase anchoring protein 8 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of AKAP8 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:11,316,224...11,332,523
Ensembl chr 7:11,316,228...11,332,399
|
|
G |
Akap8l |
A-kinase anchoring protein 8 like |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of AKAP8L mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:11,332,671...11,362,287
Ensembl chr 7:11,332,672...11,362,275
|
|
G |
Alb |
albumin |
decreases expression |
EXP |
Thiabendazole results in decreased expression of ALB mRNA |
CTD |
PMID:18539377 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Aldh9a1 |
aldehyde dehydrogenase 9 family, member A1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALDH9A1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:79,505,738...79,522,539
Ensembl chr13:79,505,695...79,540,568
|
|
G |
Alg2 |
ALG2, alpha-1,3/1,6-mannosyltransferase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ALG2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:61,768,738...61,773,297
Ensembl chr 5:61,768,740...61,773,297
|
|
G |
Angptl4 |
angiopoietin-like 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANGPTL4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:14,550,288...14,557,797
Ensembl chr 7:14,550,311...14,556,519
|
|
G |
Anks3 |
ankyrin repeat and sterile alpha motif domain containing 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ANKS3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:10,614,953...10,635,815
Ensembl chr10:10,615,047...10,635,806
|
|
G |
Anxa11 |
annexin A11 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ANXA11 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:1,412,373...1,457,814
Ensembl chr16:1,410,756...1,457,797
|
|
G |
Aplf |
aprataxin and PNKP like factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of APLF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:120,070,471...120,122,656
Ensembl chr 4:120,070,471...120,122,633
|
|
G |
Apof |
apolipoprotein F |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of APOF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:700,688...702,130
Ensembl chr 7:700,762...701,946
|
|
G |
Arf2 |
ADP-ribosylation factor 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ARF2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:88,867,836...88,889,654
Ensembl chr10:88,867,836...88,889,659
|
|
G |
Arpc1a |
actin related protein 2/3 complex, subunit 1A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of ARPC1A gene |
CTD |
PMID:33854195 |
|
NCBI chr12:9,502,496...9,525,304
Ensembl chr12:9,502,501...9,525,330
|
|
G |
Asb7 |
ankyrin repeat and SOCS box-containing 7 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ASB7 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:120,222,835...120,267,411
Ensembl chr 1:120,222,745...120,267,282
|
|
G |
Ass1 |
argininosuccinate synthase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ASS1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:14,747,355...14,796,909
Ensembl chr 3:14,747,368...14,796,903
|
|
G |
Atosa |
atos homolog A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ATOSA mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:75,694,828...75,772,565
Ensembl chr 8:75,695,022...75,772,549
|
|
G |
Atp5mc1 |
ATP synthase membrane subunit c locus 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP5MC1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:81,024,056...81,026,780
Ensembl chr10:81,023,925...81,027,124 Ensembl chr10:81,023,925...81,027,124
|
|
G |
Atp6v0d1 |
ATPase H+ transporting V0 subunit D1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ATP6V0D1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:33,403,352...33,447,357
Ensembl chr19:33,403,355...33,447,450
|
|
G |
Bag3 |
BAG cochaperone 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BAG3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:183,103,038...183,126,862
Ensembl chr 1:183,102,871...183,126,858
|
|
G |
Banp |
Btg3 associated nuclear protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BANP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:50,007,710...50,082,742
Ensembl chr19:50,007,881...50,082,738
|
|
G |
Bcl9 |
BCL9, transcription coactivator |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of BCL9 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:184,760,616...184,846,261
Ensembl chr 2:184,760,618...184,786,435
|
|
G |
Bhmt |
betaine-homocysteine S-methyltransferase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of BHMT mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:24,859,871...24,879,449
Ensembl chr 2:24,859,873...24,879,742
|
|
G |
C1qc |
complement C1q C chain |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C1QC mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:149,127,412...149,130,757
Ensembl chr 5:149,127,415...149,131,017
|
|
G |
C8h11orf54 |
similar to human chromosome 11 open reading frame 54 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of C8H11ORF54 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:12,123,839...12,146,412
Ensembl chr 8:12,123,823...12,146,473
|
|
G |
Camk2g |
calcium/calmodulin-dependent protein kinase II gamma |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CAMK2G mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:3,504,017...3,563,050
Ensembl chr15:3,504,085...3,563,050
|
|
G |
Cap1 |
cyclase associated actin cytoskeleton regulatory protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CAP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:135,142,108...135,168,885
Ensembl chr 5:135,142,112...135,168,769
|
|
G |
Caps2 |
calcyphosine 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CAPS2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:47,580,636...47,641,598
Ensembl chr 7:47,581,137...47,639,229
|
|
G |
Casp3 |
caspase 3 |
increases activity |
EXP |
Thiabendazole results in increased activity of CASP3 protein |
CTD |
PMID:26748015 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases activity |
EXP |
Thiabendazole results in increased activity of CASP8 protein |
CTD |
PMID:26748015 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases activity |
EXP |
Thiabendazole results in increased activity of CASP9 protein |
CTD |
PMID:26748015 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cbs |
cystathionine beta synthase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CBS mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:9,708,089...9,732,623
Ensembl chr20:9,708,090...9,732,764
|
|
G |
Ccdc125 |
coiled-coil domain containing 125 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCDC125 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:31,809,120...31,835,538
Ensembl chr 2:31,809,228...31,850,152
|
|
G |
Ccnl1 |
cyclin L1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CCNL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:150,184,865...150,199,524
Ensembl chr 2:150,184,798...150,197,368
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CDKN1A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cebpd |
CCAAT/enhancer binding protein delta |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CEBPD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:84,764,670...84,765,808
Ensembl chr11:84,764,565...84,765,829
|
|
G |
Cep85 |
centrosomal protein 85 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CEP85 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:146,356,571...146,404,155
Ensembl chr 5:146,356,576...146,404,060
|
|
G |
Cerk |
ceramide kinase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CERK mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:117,225,855...117,269,436
Ensembl chr 7:117,225,855...117,268,759
|
|
G |
Cfb |
complement factor B |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CFB mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:3,970,643...3,976,510
Ensembl chr20:3,951,474...3,976,505
|
|
G |
Cfl1 |
cofilin 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CFL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:202,796,012...202,801,337
Ensembl chr 1:202,786,627...202,817,587
|
|
G |
Chchd10 |
coiled-coil-helix-coiled-coil-helix domain containing 10 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CHCHD10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:12,725,839...12,727,638
Ensembl chr20:12,725,842...12,732,763
|
|
G |
Chek2 |
checkpoint kinase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CHEK2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:45,788,823...45,821,382
Ensembl chr12:45,788,827...45,821,286
|
|
G |
Chmp5 |
charged multivesicular body protein 5 |
affects expression |
EXP |
Thiabendazole affects the expression of CHMP5 mRNA |
CTD |
PMID:18539377 |
|
NCBI chr 5:56,081,385...56,098,529
Ensembl chr 5:56,081,343...56,098,529
|
|
G |
Cirbp |
cold inducible RNA binding protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CIRBP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:9,533,857...9,538,899
Ensembl chr 7:9,424,178...9,538,818
|
|
G |
Clcf1 |
cardiotrophin-like cytokine factor 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CLCF1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:201,507,763...201,517,607
Ensembl chr 1:201,507,859...201,517,605
|
|
G |
Clu |
clusterin |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CLU mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Cndp2 |
carnosine dipeptidase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CNDP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr18:78,039,924...78,057,030
Ensembl chr18:78,039,932...78,056,922
|
|
G |
Cpt2 |
carnitine palmitoyltransferase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CPT2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:122,664,677...122,682,126
Ensembl chr 5:122,664,677...122,682,095
|
|
G |
Cry1 |
cryptochrome circadian regulator 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CRY1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:18,529,823...18,594,092
Ensembl chr 7:18,529,823...18,594,091
|
|
G |
Cspp1 |
centrosome and spindle pole associated protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSPP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:9,077,161...9,192,402
Ensembl chr 5:9,077,161...9,193,377
|
|
G |
Csrnp1 |
cysteine and serine rich nuclear protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CSRNP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:119,704,712...119,717,767
Ensembl chr 8:119,704,713...119,718,183
|
|
G |
Cth |
cystathionine gamma-lyase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of CTH gene |
CTD |
PMID:33854195 |
|
NCBI chr 2:246,975,888...247,002,234
Ensembl chr 2:246,975,894...247,002,234
|
|
G |
Ctnnal1 |
catenin alpha-like 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CTNNAL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:71,514,340...71,569,431
Ensembl chr 5:71,514,340...71,569,431
|
|
G |
Cux2 |
cut-like homeobox 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CUX2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:34,507,723...34,707,581
Ensembl chr12:34,520,959...34,705,806
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression increases activity |
EXP ISO |
herbimycin inhibits the reaction [Thiabendazole results in increased activity of CYP1A1 protein]; herbimycin inhibits the reaction [Thiabendazole results in increased expression of CYP1A1 mRNA]; herbimycin inhibits the reaction [Thiabendazole results in increased expression of CYP1A1 protein] Thiabendazole results in increased expression of CYP1A1 mRNA; Thiabendazole results in increased expression of CYP1A1 protein |
CTD |
PMID:8900397 PMID:10103034 PMID:11226373 PMID:14987951 PMID:15110098 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions increases expression affects metabolic processing decreases activity |
ISO EXP |
beta-Naphthoflavone promotes the reaction [CYP1A2 protein affects the metabolism of Thiabendazole] Thiabendazole results in increased expression of CYP1A2 mRNA; Thiabendazole results in increased expression of CYP1A2 protein Thiabendazole results in decreased activity of CYP1A2 protein |
CTD |
PMID:10936227 PMID:11124226 PMID:12920490 PMID:15110098 PMID:16261361 PMID:18539377 PMID:18570159 More...
|
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression |
EXP |
Thiabendazole results in increased expression of CYP2B1 mRNA; Thiabendazole results in increased expression of CYP2B1 protein |
CTD |
PMID:15110098 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression |
EXP |
Thiabendazole results in increased expression of CYP2B2 mRNA; Thiabendazole results in increased expression of CYP2B2 protein |
CTD |
PMID:15110098 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression |
ISO |
Thiabendazole results in increased expression of CYP2B6 mRNA |
CTD |
PMID:18570159 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2c22 |
cytochrome P450, family 2, subfamily c, polypeptide 22 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP2C22 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:238,991,698...239,031,323
Ensembl chr 1:238,991,610...239,021,738
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression |
ISO |
Thiabendazole results in increased expression of CYP3A4 mRNA |
CTD |
PMID:18570159 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp4a1 |
cytochrome P450, family 4, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4A1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:129,123,323...129,137,464
Ensembl chr 5:129,123,336...129,137,464
|
|
G |
Cyp4f1 |
cytochrome P450, family 4, subfamily f, polypeptide 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of CYP4F1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:12,010,850...12,022,497
Ensembl chr 7:12,010,852...12,022,046
|
|
G |
Cytip |
cytohesin 1 interacting protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of CYTIP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:42,698,058...42,774,955
Ensembl chr 3:42,698,768...42,725,993
|
|
G |
Dbp |
D-box binding PAR bZIP transcription factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DBP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:96,175,796...96,180,745
Ensembl chr 1:96,175,440...96,180,745
|
|
G |
Dclre1c |
DNA cross-link repair 1C |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DCLRE1C mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:74,775,828...74,810,089
Ensembl chr17:74,776,935...74,809,186
|
|
G |
Ddx20 |
DEAD-box helicase 20 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DDX20 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:193,158,761...193,168,484
Ensembl chr 2:193,158,823...193,166,774
|
|
G |
Ddx5 |
DEAD-box helicase 5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DDX5 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:91,723,508...91,732,210
Ensembl chr10:91,723,508...91,732,283
|
|
G |
Dffb |
DNA fragmentation factor subunit beta |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DFFB mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:164,522,446...164,534,733
Ensembl chr 5:164,522,463...164,534,628
|
|
G |
Dlg2 |
discs large MAGUK scaffold protein 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DLG2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:144,451,653...146,503,949
Ensembl chr 1:144,451,472...146,499,475
|
|
G |
Dll1 |
delta like canonical Notch ligand 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DLL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:56,312,062...56,320,177
Ensembl chr 1:56,312,066...56,320,179
|
|
G |
Dmrt3 |
doublesex and mab-3 related transcription factor 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DMRT3 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:223,244,340...223,264,254
Ensembl chr 1:223,248,747...223,262,530
|
|
G |
Dnajb1 |
DnaJ heat shock protein family (Hsp40) member B1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:24,522,731...24,526,419
Ensembl chr19:24,522,717...24,526,458
|
|
G |
Dnajb9 |
DnaJ heat shock protein family (Hsp40) member B9 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DNAJB9 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:61,270,385...61,276,795
Ensembl chr 6:61,269,913...61,275,063
|
|
G |
Dpp4 |
dipeptidylpeptidase 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of DPP4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:46,962,233...47,043,870
Ensembl chr 3:46,962,243...47,043,901
|
|
G |
Dusp1 |
dual specificity phosphatase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DUSP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:16,680,478...16,683,275
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DUSP5 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Dusp6 |
dual specificity phosphatase 6 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of DUSP6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:34,092,848...34,097,186
Ensembl chr 7:34,092,943...34,097,185
|
|
G |
Dzip1l |
DAZ interacting zinc finger protein 1-like |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of DZIP1L gene |
CTD |
PMID:33854195 |
|
NCBI chr 8:100,188,414...100,229,077
Ensembl chr 8:100,194,999...100,228,988
|
|
G |
Emilin1 |
elastin microfibril interfacer 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of EMILIN1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:25,455,974...25,463,713
Ensembl chr 6:25,445,298...25,463,698
|
|
G |
Enpp3 |
ectonucleotide pyrophosphatase/phosphodiesterase 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ENPP3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:20,563,700...20,635,044
Ensembl chr 1:20,563,697...20,635,041
|
|
G |
Epb41l3 |
erythrocyte membrane protein band 4.1-like 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of EPB41L3 gene |
CTD |
PMID:33854195 |
|
NCBI chr 9:109,056,178...109,260,607
Ensembl chr 9:109,016,113...109,260,607
|
|
G |
Epm2aip1 |
EPM2A interacting protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of EPM2AIP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:111,233,871...111,241,219
Ensembl chr 8:111,233,826...111,241,871
|
|
G |
Erf |
Ets2 repressor factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ERF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:80,829,935...80,838,388
Ensembl chr 1:80,829,935...80,838,388
|
|
G |
Esd |
esterase D |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ESD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:50,043,634...50,063,134
Ensembl chr15:50,043,632...50,063,144
|
|
G |
Fam135a |
family with sequence similarity 135, member A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM135A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:26,420,116...26,500,803
Ensembl chr 9:26,420,528...26,500,717
|
|
G |
Fam177a1 |
family with sequence similarity 177, member A1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM177A1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 6:72,632,628...72,647,553
Ensembl chr 6:72,632,623...72,647,553
|
|
G |
Fam204a |
family with sequence similarity 204, member A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FAM204A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:259,328,551...259,366,726
Ensembl chr 1:259,337,709...259,367,077
|
|
G |
Fam53a |
family with sequence similarity 53, member A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of FAM53A gene |
CTD |
PMID:33854195 |
|
NCBI chr14:77,088,178...77,124,395
Ensembl chr14:77,090,723...77,124,395
|
|
G |
Ficd |
FIC domain protein adenylyltransferase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of FICD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:42,889,195...42,894,090
Ensembl chr12:42,889,194...42,894,070
|
|
G |
Fkbp4 |
FKBP prolyl isomerase 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of FKBP4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:161,703,379...161,711,833
Ensembl chr 4:161,703,379...161,711,833
|
|
G |
Fkbp5 |
FKBP prolyl isomerase 5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of FKBP5 gene |
CTD |
PMID:33854195 |
|
NCBI chr20:6,457,207...6,575,404
Ensembl chr20:6,457,216...6,541,674
|
|
G |
Fmn1 |
formin 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FMN1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:100,101,103...100,485,652
Ensembl chr 3:100,134,549...100,479,220
|
|
G |
Frmd4b |
FERM domain containing 4B |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FRMD4B mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:129,895,401...130,222,070
Ensembl chr 4:129,895,708...130,084,197
|
|
G |
Fzd6 |
frizzled class receptor 6 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of FZD6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:70,055,012...70,086,781
Ensembl chr 7:70,055,068...70,086,776
|
|
G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
increases expression |
EXP |
Thiabendazole results in increased expression of GADD45A mRNA |
CTD |
PMID:18539377 |
|
NCBI chr 4:96,154,789...96,157,091
Ensembl chr 4:96,154,789...96,157,115
|
|
G |
Gadd45g |
growth arrest and DNA-damage-inducible, gamma |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GADD45G mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:13,376,842...13,378,587
Ensembl chr17:13,376,839...13,378,610
|
|
G |
Gatd3a |
glutamine amidotransferase class 1 domain containing 3A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GATD3A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:10,514,793...10,522,894
Ensembl chr20:10,514,744...10,522,885
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
increases activity multiple interactions |
ISO |
Thiabendazole results in increased activity of GCLC protein [Thiabendazole co-treated with Buthionine Sulfoximine] results in increased activity of GCLC protein |
CTD |
PMID:11019651 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gdf15 |
growth differentiation factor 15 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GDF15 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:18,804,457...18,808,043
Ensembl chr16:18,805,239...18,808,055
|
|
G |
Gin1 |
gypsy retrotransposon integrase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GIN1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:98,293,596...98,315,155
Ensembl chr 9:98,293,597...98,315,848
|
|
G |
Git2 |
GIT ArfGAP 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GIT2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:41,829,717...41,872,621
Ensembl chr12:41,829,730...41,871,097
|
|
G |
Glb1 |
galactosidase, beta 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GLB1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:114,085,508...114,158,127
Ensembl chr 8:114,085,508...114,158,127
|
|
G |
Gnpda2 |
glucosamine-6-phosphate deaminase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GNPDA2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:38,520,663...38,538,713
Ensembl chr14:38,520,705...38,538,713
|
|
G |
Gprasp3 |
G protein-coupled receptor associated sorting protein family member 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GPRASP3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:98,847,591...98,854,949
Ensembl chr X:98,817,593...98,854,545
|
|
G |
Gramd1a |
GRAM domain containing 1A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of GRAMD1A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:86,367,001...86,393,348
Ensembl chr 1:86,367,001...86,393,336
|
|
G |
Gria1 |
glutamate ionotropic receptor AMPA type subunit 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of GRIA1 gene |
CTD |
PMID:33854195 |
|
NCBI chr10:41,210,713...41,527,283
Ensembl chr10:41,210,713...41,527,283
|
|
G |
Grina |
glutamate ionotropic receptor NMDA type subunit associated protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GRINA mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:107,962,194...107,965,372
Ensembl chr 7:107,962,207...107,965,366
|
|
G |
Gsdma |
gasdermin A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of GSDMA gene |
CTD |
PMID:33854195 |
|
NCBI chr10:83,614,336...83,639,543
Ensembl chr10:83,627,051...83,639,543
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of GSTK1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
EXP |
Thiabendazole results in increased expression of GSTP1 mRNA |
CTD |
PMID:15110098 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
increases expression |
EXP |
Thiabendazole results in increased expression of GSTT1 mRNA |
CTD |
PMID:15110098 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Hapstr2 |
HUWE1 associated protein modifying stress responses 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of HAPSTR2 gene |
CTD |
PMID:33854195 |
|
NCBI chr X:138,922,089...138,924,124
Ensembl chr X:138,922,100...138,922,918
|
|
G |
Hars1 |
histidyl-tRNA synthetase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HARS1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr18:28,381,649...28,398,699
Ensembl chr18:28,381,655...28,398,740
|
|
G |
Hebp1 |
heme binding protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HEBP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:167,974,316...168,003,854
Ensembl chr 4:167,974,319...168,003,854
|
|
G |
Hes1 |
hes family bHLH transcription factor 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of HES1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:70,705,763...70,708,176
Ensembl chr11:70,705,764...70,708,192
|
|
G |
Hs3st3b1 |
heparan sulfate-glucosamine 3-sulfotransferase 3B1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HS3ST3B1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:48,561,473...48,593,970
Ensembl chr10:48,561,473...48,593,970
|
|
G |
Hsd11b2 |
hydroxysteroid 11-beta dehydrogenase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSD11B2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:33,397,656...33,402,899
Ensembl chr19:33,397,656...33,402,899
|
|
G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSD17B10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:21,089,142...21,091,603
Ensembl chr X:21,089,122...21,109,488
|
|
G |
Hsd17b2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of HSD17B2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:45,753,576...45,825,203
Ensembl chr19:45,753,574...45,825,202
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPA1B mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:3,855,104...3,859,148
Ensembl chr20:3,856,006...3,873,240 Ensembl chr20:3,856,006...3,873,240
|
|
G |
Hspbp1 |
HSPA (Hsp70) binding protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of HSPBP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:69,165,394...69,189,062
Ensembl chr 1:69,165,572...69,244,593
|
|
G |
Ier3 |
immediate early response 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of IER3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:2,928,378...2,929,582
Ensembl chr20:2,928,378...2,929,583
|
|
G |
Ifna12l |
interferon alpha 12 like |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of IFNA12L gene |
CTD |
PMID:33854195 |
|
NCBI chr 5:103,476,362...103,477,427
Ensembl chr 5:103,476,657...103,477,211 Ensembl chr 5:103,476,657...103,477,211 Ensembl chr 5:103,476,657...103,477,211
|
|
G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IGFBP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:82,047,415...82,052,482
Ensembl chr14:82,047,415...82,052,482
|
|
G |
Igkv2-112l2 |
immunoglobulin kappa variable 2-112 like 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of IGKV2-112L2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 4:102,208,069...102,208,647
Ensembl chr 4:102,208,044...102,208,785
|
|
G |
Inpp5f |
inositol polyphosphate-5-phosphatase F |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of INPP5F mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:183,190,480...183,270,276
Ensembl chr 1:183,190,480...183,270,276
|
|
G |
Iqcb1 |
IQ motif containing B1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of IQCB1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:63,905,595...63,960,141
Ensembl chr11:63,905,590...63,960,093
|
|
G |
Irf2bp2 |
interferon regulatory factor 2 binding protein 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of IRF2BP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:54,559,417...54,565,096
Ensembl chr19:54,560,128...54,566,642
|
|
G |
Itprip |
inositol 1,4,5-trisphosphate receptor interacting protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of ITPRIP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:246,762,804...246,786,379
Ensembl chr 1:246,762,472...246,786,408
|
|
G |
Junb |
JunB proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of JUNB mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:23,176,265...23,178,049
Ensembl chr19:23,176,294...23,178,035
|
|
G |
Katnip |
katanin interacting protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of KATNIP gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:180,270,194...180,436,766
Ensembl chr 1:180,269,929...180,436,766
|
|
G |
Khdc4 |
KH domain containing 4, pre-mRNA splicing factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of KHDC4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:174,149,059...174,177,816
Ensembl chr 2:174,149,141...174,177,504
|
|
G |
Klf10 |
KLF transcription factor 10 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of KLF10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:69,467,658...69,473,726
Ensembl chr 7:69,465,619...69,473,994
|
|
G |
Klf2 |
KLF transcription factor 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of KLF2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:17,521,107...17,523,739
Ensembl chr16:17,514,552...17,523,944
|
|
G |
Klhl10 |
kelch-like family member 10 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of KLHL10 gene |
CTD |
PMID:33854195 |
|
NCBI chr10:85,376,442...85,392,720
Ensembl chr10:85,376,442...85,392,720
|
|
G |
Lgalsl |
galectin-like |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LGALSL mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:94,996,991...95,004,499
Ensembl chr14:94,996,990...95,004,980
|
|
G |
Lhx2 |
LIM homeobox 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of LHX2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 3:22,113,619...22,143,909
Ensembl chr 3:22,126,007...22,143,908
|
|
G |
Litaf |
lipopolysaccharide-induced TNF factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LITAF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:4,656,308...4,692,981
Ensembl chr10:4,625,552...4,692,763
|
|
G |
Lnx2 |
ligand of numb-protein X 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LNX2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:8,005,202...8,070,494
Ensembl chr12:8,005,227...8,070,494
|
|
G |
Loxl3 |
lysyl oxidase-like 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LOXL3 gene |
CTD |
PMID:33854195 |
|
NCBI chr 4:115,540,640...115,556,958
Ensembl chr 4:115,540,685...115,557,466
|
|
G |
Lpcat1 |
lysophosphatidylcholine acyltransferase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LPCAT1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:29,766,070...29,816,401
Ensembl chr 1:29,766,071...29,816,401
|
|
G |
Lpgat1 |
lysophosphatidylglycerol acyltransferase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LPGAT1 gene |
CTD |
PMID:33854195 |
|
NCBI chr13:103,294,622...103,365,372
Ensembl chr13:103,294,528...103,362,333
|
|
G |
Lpin3 |
lipin 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of LPIN3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:149,533,719...149,558,494
Ensembl chr 3:149,534,051...149,558,327
|
|
G |
Lta4h |
leukotriene A4 hydrolase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of LTA4H mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:27,969,796...28,001,600
Ensembl chr 7:27,969,789...28,001,600
|
|
G |
Lurap1l |
leucine rich adaptor protein 1-like |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of LURAP1L gene |
CTD |
PMID:33854195 |
|
NCBI chr 5:95,362,005...95,409,439
Ensembl chr 5:95,362,005...95,409,438
|
|
G |
Mapkapk2 |
MAPK activated protein kinase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MAPKAPK2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:42,513,762...42,560,061
Ensembl chr13:42,513,762...42,560,457
|
|
G |
Marf1 |
meiosis regulator and mRNA stability factor 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MARF1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:888,053...932,760
Ensembl chr10:888,076...932,753
|
|
G |
Med12l |
mediator complex subunit 12L |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MED12L mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:143,253,048...143,576,507
Ensembl chr 2:143,252,139...143,573,741
|
|
G |
Mettl14 |
methyltransferase 14, N6-adenosine-methyltransferase non-catalytic subunit |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of METTL14 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:211,530,598...211,546,845
Ensembl chr 2:211,530,602...211,546,821
|
|
G |
Mfap5 |
microfibril associated protein 5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of MFAP5 gene |
CTD |
PMID:33854195 |
|
NCBI chr 4:155,727,925...155,750,458
Ensembl chr 4:155,727,925...155,750,458
|
|
G |
Mif |
macrophage migration inhibitory factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIF mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:12,790,919...12,791,784
Ensembl chr20:12,790,902...12,799,504 Ensembl chr 4:12,790,902...12,799,504
|
|
G |
Mir122 |
microRNA 122 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR122 mRNA |
CTD |
PMID:34626815 |
|
NCBI chr18:58,758,703...58,758,787
|
|
G |
Mir130a |
microRNA 130a |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR130A mRNA |
CTD |
PMID:34626815 |
|
NCBI chr 3:69,822,542...69,822,629
Ensembl chr 3:69,822,542...69,822,629
|
|
G |
Mir146a |
microRNA 146a |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MIR146A mRNA |
CTD |
PMID:34626815 |
|
NCBI chr10:27,848,516...27,848,610
Ensembl chr10:27,848,516...27,848,610
|
|
G |
Mir193 |
microRNA 193 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR193 mRNA |
CTD |
PMID:34626815 |
|
NCBI chr10:64,672,354...64,672,439
|
|
G |
Mir22 |
microRNA 22 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR22 mRNA |
CTD |
PMID:34626815 |
|
NCBI chr10:60,307,039...60,307,133
Ensembl chr10:60,307,039...60,307,133
|
|
G |
Mir32 |
microRNA 32 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR32 mRNA |
CTD |
PMID:34626815 |
|
NCBI chr 5:71,596,083...71,596,152
Ensembl chr 5:71,596,083...71,596,152
|
|
G |
Mir33 |
microRNA 33 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MIR33 mRNA |
CTD |
PMID:34626815 |
|
NCBI chr 7:113,713,855...113,713,923
Ensembl chr 7:113,713,855...113,713,923
|
|
G |
Mir486 |
microRNA 486 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MIR486 mRNA |
CTD |
PMID:34626815 |
|
|
|
G |
Mlycd |
malonyl-CoA decarboxylase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MLYCD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:47,447,931...47,463,794
Ensembl chr19:47,447,970...47,463,793
|
|
G |
Mocs2 |
molybdenum cofactor synthesis 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MOCS2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:46,504,588...46,516,327
Ensembl chr 2:46,504,588...46,516,324
|
|
G |
Morc3 |
MORC family CW-type zinc finger 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MORC3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:33,151,906...33,194,650
Ensembl chr11:33,152,025...33,194,646
|
|
G |
Mpo |
myeloperoxidase |
increases metabolic processing |
ISO |
MPO protein results in increased metabolism of Thiabendazole metabolite |
CTD |
PMID:21513789 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Mrgbp |
MRG domain binding protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MRGBP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:167,697,129...167,700,592
Ensembl chr 3:167,697,185...167,700,592
|
|
G |
Mrnip |
MRN complex interacting protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of MRNIP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:34,501,359...34,525,474
Ensembl chr10:34,501,384...34,525,469
|
|
G |
Mrpl44 |
mitochondrial ribosomal protein L44 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MRPL44 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:81,106,658...81,111,709
Ensembl chr 9:81,106,655...81,112,812
|
|
G |
Mrps18b |
mitochondrial ribosomal protein S18B |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MRPS18B mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:2,838,174...2,844,260
Ensembl chr20:2,838,030...2,844,260
|
|
G |
Mtarc1 |
mitochondrial amidoxime reducing component 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MTARC1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:96,324,377...96,362,677
Ensembl chr13:96,339,757...96,397,796
|
|
G |
Myo10 |
myosin X |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of MYO10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:76,100,989...76,305,619
Ensembl chr 2:76,100,987...76,303,030
|
|
G |
N4bp2l2 |
NEDD4 binding protein 2-like 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of N4BP2L2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:137,342...200,292
Ensembl chr12:103,590...197,784
|
|
G |
Nae1 |
NEDD8 activating enzyme E1 subunit 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NAE1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:446,015...472,145
Ensembl chr19:446,000...472,371
|
|
G |
Ndufb11 |
NADH:ubiquinone oxidoreductase subunit B11 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of NDUFB11 gene |
CTD |
PMID:33854195 |
|
NCBI chr X:1,572,805...1,575,063
Ensembl chr X:1,572,785...1,575,062
|
|
G |
Nfe2 |
nuclear factor, erythroid 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NFE2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:134,382,758...134,395,364
Ensembl chr 7:134,382,761...134,390,108
|
|
G |
Nfil3 |
nuclear factor, interleukin 3 regulated |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of NFIL3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:12,280,499...12,295,728
Ensembl chr17:12,280,484...12,295,858
|
|
G |
Nppb |
natriuretic peptide B |
increases expression |
EXP |
Thiabendazole results in increased expression of NPPB mRNA |
CTD |
PMID:18539377 |
|
NCBI chr 5:158,416,813...158,418,175
Ensembl chr 5:158,416,866...158,418,168
|
|
G |
Nr0b2 |
nuclear receptor subfamily 0, group B, member 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NR0B2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:145,779,294...145,782,609
Ensembl chr 5:145,779,294...145,782,609
|
|
G |
Nr1d1 |
nuclear receptor subfamily 1, group D, member 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NR1D1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:83,728,348...83,735,562
Ensembl chr10:83,728,318...83,735,705
|
|
G |
Nr1d2 |
nuclear receptor subfamily 1, group D, member 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of NR1D2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:7,524,257...7,550,553
Ensembl chr15:7,524,257...7,550,553
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity |
ISO |
Thiabendazole results in increased activity of NR1I2 protein |
CTD |
PMID:25455453 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nucks1 |
nuclear casein kinase and cyclin-dependent kinase substrate 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of NUCKS1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:43,345,091...43,374,316
Ensembl chr13:43,345,115...43,370,229
|
|
G |
Olr943 |
olfactory receptor 943 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of OLR943 gene |
CTD |
PMID:33854195 |
|
NCBI chr 7:3,389,336...3,390,274
Ensembl chr 7:3,388,200...3,392,130
|
|
G |
Oplah |
5-oxoprolinase (ATP-hydrolysing) |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of OPLAH mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:108,011,472...108,051,751
Ensembl chr 7:108,011,475...108,035,297
|
|
G |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of ORAI3 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:182,381,196...182,386,055
Ensembl chr 1:182,344,293...182,386,052
|
|
G |
Oxct1 |
3-oxoacid CoA transferase 1 |
affects expression |
EXP |
Thiabendazole affects the expression of OXCT1 mRNA |
CTD |
PMID:18539377 |
|
NCBI chr 2:53,236,370...53,384,715
Ensembl chr 2:53,236,368...53,384,714
|
|
G |
Pabir1 |
PP2A Aalpha (PPP2R1A) and B55A (PPP2R2A) interacting phosphatase regulator 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PABIR1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:222,114,988...222,116,294
Ensembl chr 1:222,112,591...222,116,396
|
|
G |
Parpbp |
PARP1 binding protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of PARPBP gene |
CTD |
PMID:33854195 |
|
NCBI chr 7:22,511,427...22,580,834
Ensembl chr 7:22,511,427...22,573,695
|
|
G |
Pdlim1 |
PDZ and LIM domain 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PDLIM1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:239,042,372...239,091,074
Ensembl chr 1:239,042,385...239,091,076
|
|
G |
Pdp1 |
pyruvate dehydrogenase phosphatase catalytic subunit 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PDP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:25,446,843...25,455,107
Ensembl chr 5:25,446,272...25,455,217
|
|
G |
Pdzd2 |
PDZ domain containing 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PDZD2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 2:61,384,614...61,770,516
Ensembl chr 2:61,386,381...61,770,524
|
|
G |
Per1 |
period circadian regulator 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PER1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:53,800,126...53,814,963
Ensembl chr10:53,805,535...53,814,431
|
|
G |
Per3 |
period circadian regulator 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PER3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:161,460,228...161,495,404
Ensembl chr 5:161,459,533...161,495,607
|
|
G |
Pfkfb1 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
increases expression |
EXP |
Thiabendazole results in increased expression of PFKFB1 mRNA |
CTD |
PMID:18539377 |
|
NCBI chr X:19,508,522...19,562,165
Ensembl chr X:19,508,546...19,562,182
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PGK1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
|
|
G |
Pias3 |
protein inhibitor of activated STAT, 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PIAS3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:184,232,546...184,241,455
Ensembl chr 2:184,232,571...184,241,480
|
|
G |
Pip4p1 |
phosphatidylinositol-4,5-bisphosphate 4-phosphatase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PIP4P1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:24,146,854...24,150,739
Ensembl chr15:24,146,856...24,150,702
|
|
G |
Pirb |
paired Ig-like receptor B |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of LILRB3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:65,499,195...65,506,666
Ensembl chr 1:65,499,195...65,506,666
|
|
G |
Plekhg5 |
pleckstrin homology and RhoGEF domain containing G5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLEKHG5 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:162,577,999...162,621,518
Ensembl chr 5:162,578,071...162,621,513
|
|
G |
Plk2 |
polo-like kinase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PLK2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:41,969,176...41,974,945
Ensembl chr 2:41,969,176...41,974,947
|
|
G |
Plpp4 |
phospholipid phosphatase 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of PLPP4 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:183,829,794...183,959,319
Ensembl chr 1:183,830,409...183,959,319
|
|
G |
Pmvk |
phosphomevalonate kinase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PMVK mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:174,876,586...174,886,365
Ensembl chr 2:174,876,657...174,886,364
|
|
G |
Pnkd |
PNKD metallo-beta-lactamase domain containing |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PNKD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:75,868,620...75,937,126
Ensembl chr 9:75,867,468...75,937,124
|
|
G |
Pnrc1 |
proline-rich nuclear receptor coactivator 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PNRC1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:47,647,070...47,657,832
Ensembl chr 5:47,647,071...47,650,161
|
|
G |
Por |
cytochrome p450 oxidoreductase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of POR gene |
CTD |
PMID:33854195 |
|
NCBI chr12:20,951,058...20,999,198
Ensembl chr12:20,951,058...20,999,245
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PPARD mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Prdm15 |
PR/SET domain 15 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PRDM15 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:37,164,608...37,225,172
Ensembl chr11:37,165,575...37,222,207
|
|
G |
Prelid2 |
PRELI domain containing 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PRELID2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr18:33,869,934...33,961,320
Ensembl chr18:33,873,599...33,961,225
|
|
G |
Prelp |
proline and arginine rich end leucine rich repeat protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PRELP mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:45,368,407...45,391,480
Ensembl chr13:45,370,533...45,380,270
|
|
G |
Prkcb |
protein kinase C, beta |
increases expression |
EXP |
Thiabendazole results in increased expression of PRKCB mRNA |
CTD |
PMID:18539377 |
|
NCBI chr 1:176,832,173...177,163,539
Ensembl chr 1:176,832,226...177,163,536
|
|
G |
Proser2 |
proline and serine rich 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PROSER2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:72,151,961...72,187,524
Ensembl chr17:72,151,872...72,185,825
|
|
G |
Prpf39 |
pre-mRNA processing factor 39 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PRPF39 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:83,088,981...83,113,826
Ensembl chr 6:83,088,986...83,113,825
|
|
G |
Psmc2 |
proteasome 26S subunit, ATPase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PSMC2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:13,255,850...13,270,160
Ensembl chr 4:13,255,856...13,270,185
|
|
G |
Psmc4 |
proteasome 26S subunit, ATPase 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PSMC4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:83,349,127...83,357,497
Ensembl chr 1:83,348,592...83,357,494
|
|
G |
Psmc5 |
proteasome 26S subunit, ATPase 5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PSMC5 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:91,187,763...91,193,697
Ensembl chr10:91,187,743...91,213,135
|
|
G |
Ptpa |
protein phosphatase 2 phosphatase activator |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of PTPA mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:13,689,742...13,720,287
Ensembl chr 3:13,689,741...13,722,549
|
|
G |
Pus10 |
pseudouridine synthase 10 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of PUS10 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:97,621,228...97,684,059
Ensembl chr14:97,621,391...97,684,046
|
|
G |
Rabep1 |
rabaptin, RAB GTPase binding effector protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RABEP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:55,566,156...55,667,595
Ensembl chr10:55,566,185...55,665,973
|
|
G |
Rabl2 |
RAB, member of RAS oncogene family like 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RABL2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:120,652,175...120,660,906
Ensembl chr 7:120,652,175...120,660,783
|
|
G |
Ramac |
RNA guanine-7 methyltransferase activating subunit |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RAMAC gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:135,708,529...135,714,417
Ensembl chr 1:135,708,535...135,722,151
|
|
G |
Rangap1 |
RAN GTPase activating protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RANGAP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:113,224,695...113,250,441
Ensembl chr 7:113,224,703...113,250,438
|
|
G |
Rars1 |
arginyl-tRNA synthetase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RARS1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:20,270,744...20,295,192
Ensembl chr10:20,270,483...20,295,196
|
|
G |
Rbm14 |
RNA binding motif protein 14 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RBM14 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:202,076,940...202,105,688
Ensembl chr 1:202,078,287...202,105,665 Ensembl chr 1:202,078,287...202,105,665
|
|
G |
Rbm3 |
RNA binding motif protein 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RBM3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:14,348,909...14,352,387
Ensembl chr X:14,348,910...14,353,580
|
|
G |
Rbpms |
RNA binding protein, mRNA processing factor |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RBPMS gene |
CTD |
PMID:33854195 |
|
NCBI chr16:58,239,370...58,395,424
Ensembl chr16:58,239,474...58,395,426
|
|
G |
Resf1 |
retroelement silencing factor 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RESF1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:182,325,913...182,362,054
Ensembl chr 4:182,335,454...182,362,054
|
|
G |
Rev1 |
REV1, DNA directed polymerase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of REV1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:40,278,100...40,351,764
Ensembl chr 9:40,278,101...40,351,576
|
|
G |
Rfx7 |
regulatory factor X, 7 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RFX7 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:73,254,051...73,339,209
Ensembl chr 8:73,254,051...73,339,209
|
|
G |
Rgcc |
regulator of cell cycle |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RGCC gene |
CTD |
PMID:33854195 |
|
NCBI chr15:54,662,483...54,675,320
Ensembl chr15:54,662,483...54,681,141
|
|
G |
Rgs16 |
regulator of G-protein signaling 16 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RGS16 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:65,887,668...65,892,862
Ensembl chr13:65,887,530...65,892,857
|
|
G |
Rhobtb3 |
Rho-related BTB domain containing 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RHOBTB3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:5,363,388...5,419,164
Ensembl chr 2:5,363,388...5,419,041
|
|
G |
Rnase10 |
ribonuclease A family member 10 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of RNASE10 gene |
CTD |
PMID:33854195 |
|
NCBI chr15:24,226,687...24,229,149
Ensembl chr15:24,226,691...24,228,561
|
|
G |
Rnd3 |
Rho family GTPase 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of RND3 gene; [azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of RND3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:35,571,929...35,589,283
Ensembl chr 3:35,571,143...35,589,327
|
|
G |
Rorc |
RAR-related orphan receptor C |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of RORC mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
|
|
G |
Rxylt1 |
ribitol xylosyltransferase 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of RXYLT1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 7:57,770,841...57,782,695
Ensembl chr 7:57,770,842...57,782,657
|
|
G |
Sall4 |
spalt-like transcription factor 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SALL4 gene |
CTD |
PMID:33854195 |
|
NCBI chr 3:157,474,067...157,491,055
Ensembl chr 3:157,474,642...157,490,822
|
|
G |
Sardh |
sarcosine dehydrogenase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SARDH mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:10,510,553...10,575,342
Ensembl chr 3:10,510,553...10,573,874
|
|
G |
Scnn1a |
sodium channel epithelial 1 subunit alpha |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SCNN1A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:158,122,962...158,146,184
Ensembl chr 4:158,122,962...158,146,181
|
|
G |
Sdr42e1 |
short chain dehydrogenase/reductase family 42E, member 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SDR42E1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:45,715,366...45,727,901
Ensembl chr19:45,715,399...45,727,901
|
|
G |
Serpina1 |
serpin family A member 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SERPINA1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:122,866,314...122,888,339
Ensembl chr 6:122,866,312...122,888,339
|
|
G |
Sesn2 |
sestrin 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SESN2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:144,702,287...144,721,241
Ensembl chr 5:144,701,530...144,721,260
|
|
G |
Setd6 |
SET domain containing 6, protein lysine methyltransferase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SETD6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:9,343,309...9,350,477
Ensembl chr19:9,347,458...9,350,453
|
|
G |
Sfrp2 |
secreted frizzled-related protein 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of SFRP2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 2:169,089,517...169,097,064
Ensembl chr 2:169,089,517...169,097,063
|
|
G |
Sh3bp2 |
SH3-domain binding protein 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SH3BP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:76,176,097...76,213,300
Ensembl chr14:76,176,101...76,213,251
|
|
G |
Sigirr |
single Ig and TIR domain containing |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SIGIRR mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:196,195,363...196,208,692
Ensembl chr 1:196,199,462...196,202,269
|
|
G |
Sik2 |
salt-inducible kinase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SIK2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:51,225,543...51,325,343
Ensembl chr 8:51,225,543...51,325,415
|
|
G |
Slc12a6 |
solute carrier family 12, member 6 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SLC12A6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:99,071,577...99,170,266
Ensembl chr 3:99,071,391...99,170,258
|
|
G |
Slc20a1 |
solute carrier family 20 member 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SLC20A1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:116,427,095...116,441,049
Ensembl chr 3:116,427,098...116,441,051
|
|
G |
Slc25a39 |
solute carrier family 25, member 39 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SLC25A39 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:87,362,494...87,367,358
Ensembl chr10:87,362,490...87,367,260
|
|
G |
Slc26a6 |
solute carrier family 26 member 6 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SLC26A6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:109,558,968...109,569,778
Ensembl chr 8:109,559,642...109,569,778
|
|
G |
Slc37a2 |
solute carrier family 37 member 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SLC37A2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:36,945,787...36,971,748
Ensembl chr 8:36,946,930...36,971,482
|
|
G |
Slk |
STE20-like kinase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SLK gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:246,473,712...246,529,643
Ensembl chr 1:246,473,712...246,526,530
|
|
G |
Smad7 |
SMAD family member 7 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SMAD7 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr18:68,988,429...69,016,774
Ensembl chr18:68,988,429...69,016,765
|
|
G |
Smpx |
small muscle protein, X-linked |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SMPX gene |
CTD |
PMID:33854195 |
|
NCBI chr X:37,233,209...37,292,266
Ensembl chr X:37,234,294...37,276,708
|
|
G |
Snrnp200 |
small nuclear ribonucleoprotein U5 subunit 200 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SNRNP200 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:114,428,854...114,458,194
Ensembl chr 3:114,428,854...114,458,182
|
|
G |
Snx4 |
sorting nexin 4 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SNX4 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr11:67,460,872...67,518,143
Ensembl chr11:67,460,870...67,518,174
|
|
G |
Socs3 |
suppressor of cytokine signaling 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SOCS3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:103,193,909...103,197,322
Ensembl chr10:103,193,537...103,197,787
|
|
G |
Sod3 |
superoxide dismutase 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SOD3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Sohlh1 |
spermatogenesis and oogenesis specific basic helix-loop-helix 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of SOHLH1 gene |
CTD |
PMID:33854195 |
|
NCBI chr 3:8,662,995...8,667,521
Ensembl chr 3:8,663,318...8,667,388
|
|
G |
Spag1 |
sperm associated antigen 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SPAG1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:67,361,474...67,421,369
Ensembl chr 7:67,361,477...67,421,368
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of SRD5A2 gene |
CTD |
PMID:33854195 |
|
NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112
|
|
G |
Srrm2 |
serine/arginine repetitive matrix 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SRRM2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:12,815,471...12,848,750
Ensembl chr10:12,815,471...12,848,751
|
|
G |
Srsf5 |
serine and arginine rich splicing factor 5 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of SRSF5 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:100,605,165...100,610,192
Ensembl chr 6:100,605,456...100,610,177
|
|
G |
Stard9 |
StAR-related lipid transfer domain containing 9 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of STARD9 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:107,581,097...107,672,746
Ensembl chr 3:107,581,164...107,673,898
|
|
G |
Susd2 |
sushi domain containing 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SUSD2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:13,017,516...13,024,820
Ensembl chr20:13,017,477...13,024,903
|
|
G |
Sympk |
symplekin scaffold protein |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of SYMPK mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:78,672,372...78,700,684
Ensembl chr 1:78,672,378...78,700,684
|
|
G |
Taf9b |
TATA-box binding protein associated factor 9b |
affects expression |
EXP |
Thiabendazole affects the expression of TAF9B mRNA |
CTD |
PMID:18539377 |
|
NCBI chr X:71,289,290...71,300,142
Ensembl chr X:71,289,290...71,300,604
|
|
G |
Tat |
tyrosine aminotransferase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TAT mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:37,947,153...37,957,717
Ensembl chr19:37,947,112...37,958,031
|
|
G |
Tdp2 |
tyrosyl-DNA phosphodiesterase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TDP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:40,228,943...40,240,337
Ensembl chr17:40,228,947...40,240,313
|
|
G |
Tead2 |
TEA domain transcription factor 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TEAD2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:95,702,366...95,719,186
Ensembl chr 1:95,703,005...95,719,186
|
|
G |
Tecr |
trans-2,3-enoyl-CoA reductase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TECR mRNA |
CTD |
PMID:33854195 |
|
NCBI chr19:24,526,700...24,568,168
Ensembl chr19:24,541,615...24,568,168
|
|
G |
Tgds |
TDP-glucose 4,6-dehydratase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TGDS mRNA |
CTD |
PMID:33854195 |
|
NCBI chr15:95,175,064...95,195,555
Ensembl chr15:95,174,608...95,195,554
|
|
G |
Tgfbi |
transforming growth factor, beta induced |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TGFBI mRNA |
CTD |
PMID:33854195 |
|
NCBI chr17:7,955,603...7,984,903
Ensembl chr17:7,955,603...7,985,240
|
|
G |
Tjap1 |
tight junction associated protein 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TJAP1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:14,701,418...14,725,623
Ensembl chr 9:14,701,468...14,725,751
|
|
G |
Tkt |
transketolase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TKT mRNA |
CTD |
PMID:33854195 |
|
NCBI chr16:5,723,764...5,748,702
Ensembl chr16:5,723,762...5,748,698
|
|
G |
Tmbim6 |
transmembrane BAX inhibitor motif containing 6 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TMBIM6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:130,527,313...130,542,567
Ensembl chr 7:130,527,316...130,543,633
|
|
G |
Tmem268 |
transmembrane protein 268 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TMEM268 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:76,974,827...77,001,457
Ensembl chr 5:76,977,310...77,001,452
|
|
G |
Tmt1b |
thiol methyltransferase 1B |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TMT1B mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:1,388,876...1,391,526
Ensembl chr 7:1,388,879...1,391,526
|
|
G |
Tnfaip2 |
TNF alpha induced protein 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TNFAIP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:130,476,832...130,489,914
Ensembl chr 6:130,476,889...130,489,914
|
|
G |
Tor3a |
torsin family 3, member A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TOR3A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr13:68,769,893...68,798,738
Ensembl chr13:68,769,605...68,798,475
|
|
G |
Tp53 |
tumor protein p53 |
increases expression |
EXP |
Thiabendazole results in increased expression of TP53 mRNA |
CTD |
PMID:18539377 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Traf3ip2 |
Traf3 interacting protein 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRAF3IP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr20:43,011,405...43,054,654
Ensembl chr20:43,011,450...43,054,667
|
|
G |
Trafd1 |
TRAF type zinc finger domain containing 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRAFD1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:35,165,606...35,179,525
Ensembl chr12:35,165,606...35,179,525
|
|
G |
Trim3 |
tripartite motif-containing 3 |
increases expression |
EXP |
Thiabendazole results in increased expression of TRIM3 mRNA |
CTD |
PMID:18539377 |
|
NCBI chr 1:159,950,921...159,973,600
Ensembl chr 1:159,944,908...159,973,600
|
|
G |
Trim34 |
tripartite motif-containing 34 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of TRIM34 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:158,707,172...158,720,214
Ensembl chr 1:158,707,172...158,718,674
|
|
G |
Tsc22d3 |
TSC22 domain family, member 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of TSC22D3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:104,217,898...104,277,886
Ensembl chr X:104,217,925...104,276,861
|
|
G |
Uba3 |
ubiquitin-like modifier activating enzyme 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of UBA3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:129,789,526...129,810,707
Ensembl chr 4:129,789,204...129,810,606
|
|
G |
Ubb |
ubiquitin B |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UBB mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:47,247,630...47,249,335
Ensembl chr10:47,245,637...47,249,333
|
|
G |
Ubc |
ubiquitin C |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UBC mRNA |
CTD |
PMID:33854195 |
|
NCBI chr12:31,239,149...31,243,924
Ensembl chr12:31,239,152...31,243,925
|
|
G |
Uckl1 |
uridine-cytidine kinase 1-like 1 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of UCKL1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 3:168,674,849...168,687,513
Ensembl chr 3:168,674,849...168,698,091
|
|
G |
Ugdh |
UDP-glucose 6-dehydrogenase |
increases expression |
EXP |
Thiabendazole results in increased expression of UGDH mRNA |
CTD |
PMID:18539377 |
|
NCBI chr14:42,848,704...42,872,351
Ensembl chr14:42,848,854...42,872,354
|
|
G |
Unc45a |
unc-45 myosin chaperone A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of UNC45A mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:134,281,930...134,296,661
Ensembl chr 1:134,281,933...134,301,586
|
|
G |
Usp2 |
ubiquitin specific peptidase 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of USP2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:44,411,457...44,439,668
Ensembl chr 8:44,411,607...44,438,331
|
|
G |
Usp40 |
ubiquitin specific peptidase 40 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of USP40 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:88,607,920...88,678,940
Ensembl chr 9:88,607,930...88,678,914
|
|
G |
Utrn |
utrophin |
increases expression |
ISO |
Thiabendazole results in increased expression of UTRN mRNA |
CTD |
PMID:22028826 |
|
NCBI chr 1:6,720,854...7,224,313
Ensembl chr 1:6,722,594...7,224,313
|
|
G |
Vegfa |
vascular endothelial growth factor A |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of VEGFA mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 9:14,955,300...14,970,641
Ensembl chr 9:14,955,300...14,970,641
|
|
G |
Vnn3 |
vanin 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of VNN3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:21,571,364...21,583,626
Ensembl chr 1:21,571,364...21,583,626
|
|
G |
Vtn |
vitronectin |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of VTN mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:63,394,732...63,397,812
Ensembl chr10:63,394,719...63,397,810
|
|
G |
Wdr11 |
WD repeat domain 11 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of WDR11 gene |
CTD |
PMID:33854195 |
|
NCBI chr 1:184,165,260...184,210,834
Ensembl chr 1:184,165,571...184,210,846
|
|
G |
Wee1 |
WEE1 G2 checkpoint kinase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased expression of WEE1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 1:164,173,681...164,197,688
Ensembl chr 1:164,174,779...164,197,688
|
|
G |
Wfdc9 |
WAP four-disulfide core domain 9 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased methylation of WFDC9 gene |
CTD |
PMID:33854195 |
|
NCBI chr 3:153,380,554...153,389,055
Ensembl chr 3:153,380,649...153,391,261
|
|
G |
Yod1 |
YOD1 deubiquitinase |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in decreased methylation of YOD1 gene |
CTD |
PMID:33854195 |
|
NCBI chr13:42,175,047...42,181,661
Ensembl chr13:42,174,820...42,177,205
|
|
G |
Zfc3h1 |
zinc finger, C3H1-type containing |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFC3H1 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 7:51,008,251...51,064,666
Ensembl chr 7:51,007,984...51,064,661
|
|
G |
Zfp280d |
zinc finger protein 280D |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP280D mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 8:72,992,655...73,080,482
Ensembl chr 8:72,992,650...73,080,480
|
|
G |
Zfp36l2 |
zinc finger protein 36, C3H type-like 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP36L2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 6:10,490,032...10,494,073
Ensembl chr 6:10,490,032...10,494,064
|
|
G |
Zfp422 |
zinc finger protein 422 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP422 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 4:149,885,805...149,893,287
Ensembl chr 4:149,885,600...149,893,257
|
|
G |
Zfp598 |
zinc finger protein 598 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZFP598 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr10:13,694,224...13,706,235
Ensembl chr10:13,694,286...13,706,233
|
|
G |
Zmym3 |
zinc finger MYM-type containing 3 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZMYM3 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr X:66,528,585...66,544,234
Ensembl chr X:66,528,585...66,544,782
|
|
G |
Zmym6 |
zinc finger MYM-type containing 6 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZMYM6 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 5:139,396,374...139,444,357
Ensembl chr 5:139,396,727...139,444,279
|
|
G |
Zranb2 |
zinc finger RANBP2-type containing 2 |
multiple interactions |
EXP |
[azoxystrobin co-treated with 2-chloro-N-(4-chlorobiphenyl-2-yl)nicotinamide co-treated with Chlorpyrifos co-treated with Glyphosate co-treated with imidacloprid co-treated with Thiabendazole] results in increased expression of ZRANB2 mRNA |
CTD |
PMID:33854195 |
|
NCBI chr 2:246,573,110...246,586,942
Ensembl chr 2:246,573,166...246,586,942
|
|